Hanwha Chemical
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- -
- Established
- 1952-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.hanwhacorp.co.kr
Safety and Pharmacokinetic Characteristics of HD203 Liquid in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Biological: Etanercept (Enbrel)Biological: HD203
- First Posted Date
- 2013-07-10
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Hanwha Chemical
- Target Recruit Count
- 48
- Registration Number
- NCT01894412
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Safety and Pharmacokinetic Characteristics of HD203 Liq. in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Biological: Etanercept (Enbrel)Biological: HD203
- First Posted Date
- 2011-09-09
- Last Posted Date
- 2013-07-08
- Lead Sponsor
- Hanwha Chemical
- Target Recruit Count
- 44
- Registration Number
- NCT01431404
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA Patients
Phase 3
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- Biological: Etanercept
- First Posted Date
- 2011-01-06
- Last Posted Date
- 2014-07-15
- Lead Sponsor
- Hanwha Chemical
- Target Recruit Count
- 294
- Registration Number
- NCT01270997
- Locations
- 🇰🇷
Hospetal for Rheumatic Diseases Hanyang University Medical Center, Seoul, Korea, Republic of
Safety and Pharmacokinetic Characteristics of HD203 in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Biological: HD203
- First Posted Date
- 2010-01-08
- Last Posted Date
- 2014-07-15
- Lead Sponsor
- Hanwha Chemical
- Target Recruit Count
- 42
- Registration Number
- NCT01044836
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath